Company: RPTX
Filing Date: 2025-12-03
Form Type: PREM14A
Source: 0001193125-25-306948
Chunk: 336

Company: Repare Therapeutics Inc.
Filing Date: 2025-12-03
Form: PREM14A
Chunk 336
---
 manufacture and
commercialize on potential new product candidates for the treatment of cancer pursuant to that certain Collaboration and License Agreement, dated as of May 26, 2020, as amended, restated, modified, replaced and novated from time to time (the
“Second Partnership Agreement”); and (iii) DCx Biotherapeutics Corporation to out-license certain early-stage discovery platforms pursuant to that certain Asset Purchase and
License Agreement, dated as of May 1, 2025, as amended, restated, modified, replaced and novated from time to time (the “Third Partnership Agreement”).

“Existing Partnership Agreement” means each of the First Partnership Agreement, the Second Partnership
Agreement and the Third Partnership Agreement.

“Existing Partnership Percentage” means (i) for the period
beginning the date hereof and ending on the second (2) anniversary hereof, ninety percent (90%) of Net Proceeds, (ii) for the period beginning on the second (2) anniversary hereof and ending on the fourth (4) anniversary hereof, eighty five percent (85%) of Net Proceeds, (iii) for the period
beginning on the fourth (4) anniversary hereof and ending on the sixth (6) anniversary hereof, eighty percent (80%) of Net Proceeds, and
(iv) for the period beginning on the sixth (6) anniversary hereof and ending on the Expiration Date, seventy five percent (75%) of Net Proceeds.

A-88

“Existing Partnership Period” means the period
beginning on the Closing and ending on the tenth (10) anniversary of the Closing.

“Existing Partnership Proceeds” means, without duplication, Existing Partnership Percentage of the Net
Proceeds, in the case of Gross Proceeds as payable to Purchaser or any of its Affiliates, including the Company (after the Closing), or is otherwise due to or received by Purchaser or any of its Affiliates, including the Company (after the Closing),
in respect of any Existing Partnership during the Existing Partnership Period. For the avoidance of doubt, no amounts received pursuant to the Third Partnership Agreement and treated as Additional Receivables shall be Existing Partnership Proceeds.

“Expiration Date” means tenth (10) anniversary of the
Closing.

“Gross Proceeds” means, without duplication, the sum of all cash consideration and the value of any
and all consideration of any kind that is payable to Purchaser or any of its Affiliates, including the